SCHEMBL27433004

SCHEMBL27433004

O=C(NCC1CO1)C(Cl)Cl

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
ALDH1A2 O94788 1/20 0.43
ALDH2 P05091 1/20 0.43
ALDH1A3 P47895 1/20 0.43
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.35
HPGD P15428 6/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
USP2 O75604 1/20 0.33
MTNR1A P48039 1/20 0.33
TP53 P04637 1/20 0.33
ALOX12 P18054 1/20 0.33
TDP1 Q9NUW8 1/20 0.32
POLB P06746 1/20 0.32
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
TSHR P16473 2/20 0.31
HTT P42858 1/20 0.31
F10 P00742 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13470294 0.84 HPGD (0.38) KMT2AMEN1HPGDSMN1; SMN2USP2
SCHEMBL23328066 0.79 MEN1 (0.38) KMT2AMEN1HPGDSMN1; SMN2USP2
SCHEMBL4178226 0.79 ALDH1A2 (0.43) ALDH1A1ALDH1A2ALDH2ALDH1A3KMT2A
SCHEMBL8635741 0.75 LMNA (0.42) ALDH1A1KMT2AMEN1HPGDSMN1; SMN2
SCHEMBL11421378 0.75 HPGD (0.43) ALDH1A1KMT2AMEN1HPGDSMN1; SMN2
SCHEMBL13854071 0.75 MEN1 (0.36) KMT2AMEN1HPGDUSP2MTNR1A
SCHEMBL3832973 0.73
SCHEMBL3832969 0.73
SCHEMBL16197619 0.73
Methane SCHEMBL28536154 0.73 HPGD (0.42) ALDH1A1KMT2AMEN1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240217917-A1 PHOTOLYTICALLY DEGRADABLE COMPOUNDS AND METHODS THE UNIVERSITY OF STAVANGER (NO) 2024-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240217917-A1 PHOTOLYTICALLY DEGRADABLE COMPOUNDS AND METHODS DDT, DDC, CTRC ALDH1A1 1873/4885ALDH1A2 618/4885ALDH2 1929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.